Clinical trial
A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated…
NCT00239577 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00239577 |
|---|---|
| Title | A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults |
| Official title | Observer-blind, Single Center, Controlled Study of 2 Doses of Various Formulations of the WRAIR Live Attenuated Tetravalent Dengue Vaccine Compared to a Placebo Control, Administered on a 0-6-month Schedule, to Healthy Adults |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Dengue |
| Intervention type | Biological |
| Interventions | Live attenuated tetravalent dengue vaccine, Placebo |
| Enrollment | 86 |
| Start date | Apr 5, 2006 |
| Primary completion | Jun 19, 2007 |
| Completion | Jun 19, 2007 |
| First posted | Oct 17, 2005 |
| Last update posted | Feb 19, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: